| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 2 securities · may seek to influence control | ||||||
|
Psyence Biomedical Ltd.
13D/A
PBM · 74449F407
|
49.8% |
10/15/2026
Event 10/1/2026
|
||||
|
Psyence Biomedical Ltd.
13D
PBM · 74449F308
|
30.1% |
6/3/2026
Event 2/25/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.